drugset / Trial / NCT07240077
Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia
Timeline
- Start
- 2026-01-01
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levofloxacin | Small molecule | 750 mg | Intravenous |